blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1940817

EP1940817 - CHOLINERGIC ENHANCERS WITH IMPROVED BLOOD-BRAIN BARRIER PERMEABILITY FOR THE TREATMENT OF DISEASES ACCOMPANIED BY COGNITIVE IMPAIRMENT [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  09.11.2012
Database last updated on 25.09.2024
Most recent event   Tooltip11.01.2013Lapse of the patent in a contracting state
New state(s): CH, LI, TR		published on 13.02.2013  [2013/07]
Applicant(s)For all designated states
Galantos Pharma GmbH
Biotechnikum an der Goldgrube Freiligrathstrasse 12
55131 Mainz / DE
[2008/28]
Inventor(s)01 / MAELICKE, Alfred
Hinter der Hecke 1
55268 Nieder-Olm / DE
 [2008/28]
Representative(s)Boeckh, Tobias, et al
Hertin und Partner
Rechts- und Patentanwälte PartG mbB
Kurfürstendamm 54/55
10707 Berlin / DE
[N/P]
Former [2010/39]Boeckh, Tobias, et al
HERTIN Anwaltssozietät Kurfürstendamm 54/55
10707 Berlin / DE
Former [2010/36]Boeckh, Tobias
HERTIN Anwaltssozietät Kurfürstendamm 54/55
10707 Berlin / DE
Former [2010/36]Polypatent
Postfach 40 02 43
51410 Bergisch Gladbach / DE
Former [2010/01]Polypatent
Postfach 40 02 43
51410 Bergisch Gladbach / DE
Former [2008/28]Polypatent
Braunsberger Feld 29
51429 Bergisch Gladbach / DE
Application number, filing date06792225.222.09.2006
[2008/28]
WO2006EP09220
Priority number, dateEP2005002072122.09.2005         Original published format: EP 05020721
US20060780243P07.03.2006         Original published format: US 780243 P
[2008/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007039138
Date:12.04.2007
Language:EN
[2007/15]
Type: A1 Application with search report 
No.:EP1940817
Date:09.07.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 12.04.2007 takes the place of the publication of the European patent application.
[2008/28]
Type: B1 Patent specification 
No.:EP1940817
Date:07.07.2010
Language:EN
[2010/27]
Search report(s)International search report - published on:EP12.04.2007
ClassificationIPC:C07D307/91, C07D491/06, A61K31/343, A61K31/55, A61P25/28, C07D307/00, C07D223/00
[2008/28]
CPC:
A61K31/55 (EP,US); A61K31/343 (EP,US); A61P25/00 (EP);
A61P25/28 (EP); C07D307/91 (EP,US); C07D405/12 (EP,US);
C07D491/06 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/28]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:CHOLINERGE ENHANCER MIT VERBESSERTER DURCHGÄNGIGKEIT DURCH DIE BLUT-HIRN-SCHRANKE ZUR BEHANDLUNG VON KRANKHEITEN, DIE MIT KOGNITIVEN STÖRUNGEN EINHERGEHEN[2008/28]
English:CHOLINERGIC ENHANCERS WITH IMPROVED BLOOD-BRAIN BARRIER PERMEABILITY FOR THE TREATMENT OF DISEASES ACCOMPANIED BY COGNITIVE IMPAIRMENT[2008/28]
French:AMPLIFICATEURS CHOLINERGIQUES DE PERMÉABILITÉ DE LA BARRIÈRE SANG-CERVEAU AMÉLIORÉE POUR LE TRAITEMENT DE MALADIES ACCOMPAGNÉES D'UNE DÉFICIENCE COGNITIVE[2008/28]
Entry into regional phase19.03.2008National basic fee paid 
19.03.2008Designation fee(s) paid 
19.03.2008Examination fee paid 
Examination procedure02.06.2007Request for preliminary examination filed
International Preliminary Examining Authority: EP
19.03.2008Examination requested  [2008/28]
06.06.2008Amendment by applicant (claims and/or description)
06.04.2009Despatch of a communication from the examining division (Time limit: M04)
27.05.2009Reply to a communication from the examining division
18.08.2009Despatch of a communication from the examining division (Time limit: M04)
15.09.2009Reply to a communication from the examining division
06.11.2009Despatch of a communication from the examining division (Time limit: M02)
23.11.2009Reply to a communication from the examining division
14.04.2010Communication of intention to grant the patent
21.05.2010Fee for grant paid
21.05.2010Fee for publishing/printing paid
Opposition(s)Opponent(s)01  05.04.2011  16.05.2012  WITHDRAWN
Sanochemia Pharmazeutika AG
Boltzmanngasse 11
1090 Wien / AT
Opponent's representative
Beer, Manfred, et al, et al
BEER & PARTNER PATENTANWÄLTE KG
Lindengasse 8
1070 Wien / AT
 02  07.04.2011  12.04.2011  ADMISSIBLE
Synaptech Inc.
P. O. Box 157
Cold Spring Harbor NY 11724 / US
Opponent's representative
Richards, John, et al, et al
Ladas & Parry LLP
Temple Chambers
3-7 Temple Avenue
London EC4Y 0DA / GB
 [N/P]
Former [2012/26]
Opponent(s)01  05.04.2011  16.05.2012  WITHDRAWN
Sanochemia Pharmazeutika AG
Boltzmanngasse 11
1090 Wien / AT
Opponent's representative
Beer, Manfred, et al, et al
BEER & PARTNER PATENTANWÄLTE KG Lindengasse 8
1070 Wien / AT
 02  07.04.2011  12.04.2011  ADMISSIBLE
Synaptech Inc.
P. O. Box 157
Cold Spring Harbor NY 11724 / US
Opponent's representative
Richards, John, et al, et al
Ladas & Parry LLP Dachauerstrasse 37
80335 München / DE
Former [2011/20]
Opponent(s)01  05.04.2011  13.04.2011  ADMISSIBLE
Sanochemia Pharmazeutika AG
Boltzmanngasse 11
1090 Wien / AT
Opponent's representative
Beer, Manfred, et al, et al
BEER & PARTNER PATENTANWÄLTE KG Lindengasse 8
1070 Wien / AT
 02  07.04.2011  12.04.2011  ADMISSIBLE
Synaptech Inc.
P. O. Box 157
Cold Spring Harbor NY 11724 / US
Opponent's representative
Richards, John, et al, et al
Ladas & Parry LLP Dachauerstrasse 37
80335 München / DE
Former [2011/19]
Opponent(s)01  05.04.2011    WITHDRAWN
Sanochemia Pharmazeutika AG
Boltzmanngasse 11
1090 Wien / AT
Opponent's representative
Beer, Manfred, et al, et al
BEER & PARTNER PATENTANWÄLTE KG Lindengasse 8
1070 Wien / AT
12.05.2011Invitation to proprietor to file observations on the notice of opposition
13.09.2011Reply of patent proprietor to notice(s) of opposition
12.06.2012Date of oral proceedings
12.06.2012Legal effect of revocation of patent [2012/50]
17.07.2012Despatch of minutes of oral proceedings
17.07.2012Despatch of communication that the patent will be revoked
Fees paidRenewal fee
19.08.2008Renewal fee patent year 03
01.09.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH07.07.2010
EE07.07.2010
LI07.07.2010
RO07.07.2010
SK07.07.2010
TR07.07.2010
BG07.10.2010
[2013/07]
Former [2011/29]EE07.07.2010
RO07.07.2010
SK07.07.2010
BG07.10.2010
Former [2011/23]EE07.07.2010
SK07.07.2010
BG07.10.2010
Former [2011/18]BG07.10.2010
Cited inInternational search[X]WO8808708  (BONNIE DAVIS [US]) [X] 1-11 * claim 1 *;
 [X]EP0653427  (HOECHST ROUSSEL PHARMA [US]) [X] 1-11 * page 2, line 30 * * tables I-III * * examples 2-17 * * claims 1-9 *;
 [X]EP0648771  (HOECHST ROUSSEL PHARMA [US]) [X] 1-11 * page 2, line 23 * * tables I-III * * examples 2-18 * * claims 1-8 *;
 [X]EP1020470  (SYNAPTECH INC [US]) [X] 1-11 * page 2, line 31 * * tables I-III * * examples 2-21 * * claims 1-9 *;
 [X]JP2003026683  ;
 [X]WO0033840  (BONNIE DAVIS [US]) [X] 4-11 * page 3, line 20 * * page 3, paragraph L - page 4, paragraph 2 *;
 [X]WO9908672  (SHIRE INTERNATIONAL LICENSING [NL], et al) [X] 4-11 * claims 1,9,12 *;
 [X]EP0384676  (SMITHKLINE BEECHAM CORP [US]) [X] 4-11 * claims 1-9 *;
 [Y]EP0515301  (SNORRASON ERNIR [IS]) [Y] 1-11 * page 5, line 17 - line 49 * * page 7; compound I * * page 4, line 26 - line 34 *
 [X]  - PATENT ABSTRACTS OF JAPAN, (20030512), vol. 2003, no. 05, & JP2003026683 A 20030129 (SANKYO CO LTD) [X] 1-11 * abstract *
 [Y]  - ZHANG, LIFEN ET AL, "Cholinergic drugs for Alzheimer 's disease enhance in vitro dopamine release", MOLECULAR PHARMACOLOGY , 66(3), 538-544 CODEN: MOPMA3; ISSN: 0026-895X, (2004), XP002367049 [Y] 1-11 * abstract *

DOI:   http://dx.doi.org/10.1124/mol.104.000299
by applicantWO0033840
 EP1020470
 JP2003026683
 WO9908672
 EP0384676
 EP0515301
    - ZHANG ET AL., MOLECULAR PHARMACOLOGY, (2004), vol. 66, no. 3, pages 538 - 544
    - MANNENS ET AL., DRUG METABOLISM AND DISPOSITION, (2002), vol. 30, no. 5, pages 553 - 563
    - SCHRATTENHOLZ A ET AL., MOL PHARMACOL, (1996), vol. 49, pages 1 - 6
    - SAMOCHOCKI M ET AL., ACTA NEURO SCAND, (2000), vol. 176, pages 68 - 73
    - SAMOCHOCKI M ET AL., J PHARMACOL EXP THERAP, (2003), vol. 305, pages 1024 - 1036
    - ELLMAN ET AL., BIOCHEM. PHARMACOL., (1961), vol. 7, page 88
    - KIHARA T ET AL., BIOCHEM BIOPHYS RES COMMUN, (2004), vol. 325, pages 976 - 982
    - ARIAS E ET AL., NEUROPHARMACOL, (2003), vol. 46, pages 103 - IS 14
    - CAPSONI ET AL., PROC NATL ACAD SCI USA, (2002), vol. 99, pages 12432 - 12437
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.